Technical Analysis for CSTL - Castle Biosciences, Inc.

Grade Last Price % Change Price Change
grade C 20.25 -1.22% -0.25
CSTL closed down 1.22 percent on Friday, August 16, 2019, on 31 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical CSTL trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Multiple of Ten Bullish Other 0.00%
Down 3 Days in a Row Weakness 0.00%
Hot IPO Pullback Bullish Swing Setup -1.22%
Multiple of Ten Bullish Other -5.59%
NR7 Range Contraction -2.46%
Inside Day Range Contraction -2.46%
Bullish Engulfing Bullish -5.86%
Morning Star Bullish -5.86%

Older signals for CSTL ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:
Profile
Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The company offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, which is a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
Medicine Health Cancer Clinical Medicine Medical Tests Gene Expression Melanoma Metastasis
Is CSTL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 0 bearish and 5 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Aug 17 The Week Ahead In Biotech: FDA Goes Into Overdrive In A Quiet Week
Jul 29 Castle Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jul 26 Castle Biosciences IPO: The Buying Opportunity Starts At 3x-3.5x Sales
Jul 25 Castle Biosciences prices IPO at upper end of range
Jul 25 Castle Biosciences Announces Pricing of Initial Public Offering
Jul 22 Castle Biosciences IPO: What You Need To Know
Jul 21 IPO Outlook For The Week: Biotech, Health Analytics, Sports And Solar Power
See more CSTL news...
Indicators
Indicator Value
52 Week High 24.7483
52 Week Low 17.11
Average Volume 144,106
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 20.766
Average True Range 2.1329
ADX 0.0
+DI 14.4832
-DI 20.3315
Chandelier Exit (Long, 3 ATRs ) 18.3496
Chandelier Exit (Short, 3 ATRs ) 23.5087
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line -0.204
MACD Signal Line -0.0722
MACD Histogram -0.1318
Fundamentals Value
Market Cap 81.24 Thousand
Num Shares 4.01 Thousand
EPS 0.15
Price-to-Earnings (P/E) Ratio 135.91
Price-to-Sales 1.19
Price-to-Book 1.38
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.98
Resistance 3 (R3) 21.94 21.33 21.69
Resistance 2 (R2) 21.33 20.89 21.35 21.59
Resistance 1 (R1) 20.79 20.62 20.49 20.83 21.50
Pivot Point 20.18 20.18 20.03 20.20 20.18
Support 1 (S1) 19.64 19.74 19.34 19.68 19.00
Support 2 (S2) 19.03 19.47 19.05 18.91
Support 3 (S3) 18.49 19.03 18.81
Support 4 (S4) 18.53